Risk Factors of Death in Chronic Obstructive Pulmonary Disease (COPD) Patients at Dr. Soetomo General Academic Hospital, Surabaya, in 2019
Downloads
Highlights:
-
The highest distribution of chronic obstructive pulmonary disease (COPD) patients’ age and gender was over 60 years old and males.
- The highest distribution of COPD patients’ comorbidity was infection, with pneumonia being the most common infection.
Abstract
Introduction: The distribution of death and risk factors in chronic obstructive pulmonary disease (COPD) patients varies according to disease severity. This study aimed to determine the risk factors of mortality in COPD patients.
Methods: This was a retrospective descriptive study with a total sampling method using inclusion and exclusion criteria. Data collection was performed on patients' medical records throughout 2019. The inclusion criteria for this study sample were patients diagnosed with COPD who died in 2019, aged over 25 years old (adults), both male and female. The exclusion criteria were COPD patients with incomplete medical record data.
Results: The total number of samples obtained and included in this study was 31 COPD patients (n=31). The characteristics of the patients showed a predominance of males over females, with a ratio of 9:1. Seventeen samples (58.0%) out of 31 were patients aged >66 years old. Comorbidities accounted for 96.8% of the study population. The most prevalent comorbidity was infection (77.41%), with pneumonia accounting for 38.7% of all deaths. Eighteen patients (58.1%) reported having two or more comorbidities, whilst 28 patients (90.3%) scored 0-7 on the Modified Sequential Organ Failure Assessment (mSOFA) when admitted to the hospital.
Conclusion: This study found that the group of patients with the mSOFA score of 0-7 with the characteristics of being aged >60 years old, males, and having pneumonia infection had the highest mortality rate among other COPD patients who died.
Singh D, Agusti A, Anzueto A, Barnes PJ, Bourbeau J, Celli BR, et al. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease: The GOLD Science Committee Report 2019. Eur Respir J; 53. May 2019. [PubMed]
Agarwal AK, Raja A, Brown BD. Chronic Obstructive Pulmonary Disease. Treasure Island (FL), 2024. [PubMed]
Ruvuna L, Sood A. Epidemiology of Chronic Obstructive Pulmonary Disease. Clin Chest Med 2020; 41: 315–327. [PubMed]
World Health Organization (WHO). Global Health Estimates. Geneva, (2020). [Website]
North CM, Kakuhikire B, Vořechovská D, Hausammann-Kigozi S, McDonough AQ, Downey J, et al. Prevalence and Correlates of Chronic Obstructive Pulmonary Disease and Chronic Respiratory Symptoms in Rural Southwestern Uganda: A Cross-Sectional, Population-Based Study. J Glob Health 2019; 9: 10434. [PubMed]
World Health Organization (WHO). Noncommunicable Diseases Country Profiles 2018. Geneva, (2018). [Website]
Xie M, Liu X, Cao X, Guo M, Li X. Trends in Prevalence and Incidence of Chronic Respiratory Diseases from 1990 to 2017. Respir Res 2020; 21: 49. [PubMed]
Olortegui-Rodriguez JJ, Soriano-Moreno DR, Benites-Bullón A, Pelayo-Luis PP, Huaringa-Marcelo J. Prevalence and Incidence of Chronic Obstructive Pulmonary Disease in Latin America and the Caribbean: A Systematic Review and Meta-Analysis. BMC Pulm Med 2022; 22: 273. [PubMed]
Gut-Gobert C, Cavaillès A, Dixmier A, Guillot S, Jouneau S, Leroyer C, et al. Women and COPD: Do We Need More Evidence? Eur Respir Rev; 28. March 2019. [PubMed]
Park SC, Kim DW, Park EC, Shin CS, Rhee CK, Kang YA, et al. Mortality of Patients with Chronic Obstructive Pulmonary Disease: A Nationwide Population Based Cohort Study. Korean J Intern Med 2019; 34: 1272–1278. [PubMed]
Park HY, Kang D, Lee H, Shin SH, Kang M, Kong S, et al. Impact of Chronic Obstructive Pulmonary Disease on Mortality: A Large National Cohort Study. Respirology 2020; 25: 726–734. [PubMed]
Divo MJ, Marin JM, Casanova C, Lopez CC, Pinto-Plata VM, Marin-Oto M, et al. Comorbidities and Mortality Risk in Adults Younger than 50 Years of Age with Chronic Obstructive Pulmonary Disease. Respir Res 2022; 23: 267. [PubMed]
Mosenifar Z. Chronic Obstructive Pulmonary Disease (COPD). Medscape, (2022). [Website]
Zhang Y, Wang L, Mutlu GM, Cai H. More to Explore: Further Definition of Risk Factors for COPD - Differential Gender Difference, Modest Elevation in PM(2).(5), and e-Cigarette Use. Front Physiol 2021; 12: 669152. [PubMed]
Firdausi NL. Analisis Faktor Risiko yang Berhubungan dengan Kejadian Penyakit Paru Obstruksi Kronis (PPOK) di Indonesia. Faculty of Public Health Universitas Airlangga Surabaya, (2020). [Website]
Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease (2020 Report), (2020). [Website]
Astuti MF, Utomo B, Suparmin S. Beberapa Faktor Risiko yang Berhubungan dengan Penyakit Paru Obstruktif Kronik (PPOK) Petugas Kebersihan di Kota Purwokerto Tahun 2017. Bul Keslingmas Bul Kesehat Lingkung Masy 2018; 37: 443–455. [Journal]
Cho SJ, Stout-Delgado HW. Aging and Lung Disease. Annu Rev Physiol 2020; 82: 433–459. [PubMed]
Nurfaizi A, Marhana IA, Sari GM, Bakhtiar A. Correlation between FEV1% Predicted and Blood Eosinophils in Patients with Exacerbations of Chronic Obstructive Pulmonary Disease (COPD). J Respirasi 2021; 7: 59–64. [Journal]
Kim-Dorner SJ, Schmidt T, Kuhlmann A, von der Schulenburg JMG, Welte T, Lingner H. Age- and Gender-Based Comorbidity Categories in General Practitioner and Pulmonology Patients with COPD. NPJ Prim Care Respir Med 2022; 32: 17. [PubMed]
Lee K, Lee H, Lee K, Hong S, Shin H, Lee G. Gender Differences in Pulmonary Function, Physical Activity, and Quality of Life of Patients with COPD Based on Data from the Korea National Health and Nutrition Examination Survey 2015 to 2019 from the Perspective of Pulmonary Rehabilitation. Medicine (Baltimore) 2022; 101: e31413. [PubMed]
Shukla SD, Shastri MD, Jha NK, Gupta G, Chellappan DK, Bagade T, et al. Female Gender as a Risk Factor for Developing COPD. EXCLI J 2021; 20: 1290–1293. [PubMed]
Zysman M, Raherison-Semjen C. Women’s COPD. Medicine (Baltimore) 2021; 8: 600107. [PubMed]
Australia LF. The COPD-X Plan: Australian and New Zealand Guidelines for the Management of Chronic Obstructive Pulmonary Disease 2020. Brisbane, (2020). [Website]
Spece LJ, Epler EM, Donovan LM, Griffith MF, Collins MP, Feemster LC, et al. Role of Comorbidities in Treatment and Outcomes after Chronic Obstructive Pulmonary Disease Exacerbations. Ann Am Thorac Soc 2018; 15: 1033–1038. [PubMed]
Safiri S, Carson-Chahhoud K, Noori M, Nejadghaderi SA, Sullman MJM, Heris JA, et al. Burden of Chronic Obstructive Pulmonary Disease and Its Attributable Risk Factors in 204c Countries and Territories, 1990-2019: Results from the Global Burden of Disease Study 2019. BMJ 2022; 378: e069679. [PubMed]
Putra RGP. Pola Pasien Penyakit Paru Obstruksi Kronis (PPOK) Eksaserbasi di Rumah Sakit Umum Daerah Dr. Saiful Anwar Malang Tahun 2016-2017. Universitas Brawijaya Malang, (2019). [Website]
Singh D, Mathioudakis AG, Higham A. Chronic Obstructive Pulmonary Disease and COVID-19: Interrelationships. Curr Opin Pulm Med 2022; 28: 76–83. [PubMed]
Mathioudakis AG, Janssens W, Sivapalan P, Singanayagam A, Dransfield MT, Jensen JUS, et al. Acute Exacerbations of Chronic Obstructive Pulmonary Disease: In Search of Diagnostic Biomarkers and Treatable Traits. Thorax 2020; 75: 520–527. [PubMed]
Wang X, Xie Z, Xiong S, Xiong W, Zhong T, Su Y. Acute Kidney Injury in Hospitalized Patients with Nonexacerbated Chronic Obstructive Pulmonary Disease. BMC Pulm Med 2020; 20: 108. [PubMed]
Zheng Y, Huang Y, Zheng X, Peng J, Chen Y, Yu K, et al. Deaths from COPD in Patients with Cancer: A Population-Based Study. Aging (Albany NY) 2021; 13: 12641–12659. [PubMed]
Lisspers K, Larsson K, Janson C, Ställberg B, Tsiligianni I, Gutzwiller FS, et al. Gender Differences among Swedish COPD Patients: Results from the ARCTIC, a Real-World Retrospective Cohort Study. NPJ Prim Care Respir Med 2019; 29: 45. [PubMed]
El-Naggar TAEH, Raafat RH, Mohamed SA. Validity of Three Scoring Systems in Assessing the Severity and Outcome in Al-Abbassia Chest Hospital Respiratory Intensive Care Unit patients. Egypt J Bronchol 2018; 12: 208–217. [Springer]
Jentzer JC, Bennett C, Wiley BM, Murphree DH, Keegan MT, Gajic O, et al. Predictive Value of the Sequential Organ Failure Assessment Score for Mortality in a Contemporary Cardiac Intensive Care Unit Population. J Am Heart Assoc; 7. March 2018. [PubMed]
Administration for Strategic Preparedness and Response (ASPR). SOFA Score: What it is and How to Use it in Triage, (2020). [Website]
Copyright (c) 2025 Hilmy Indra Wedhana, Arief Bakhtiar, Edward Kusuma, Alfian Nur Rosyid
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
1. The journal allows the author to hold the copyright of the article without restrictions.
2. The journal allows the author(s) to retain publishing rights without restrictions
3. The formal legal aspect of journal publication accessibility refers to Creative Commons Atribution-Share Alike 4.0 (CC BY-SA).
